Repeated allergen exposure reduce early phase airway response and leukotriene release despite upregulation of 5-lipoxygenase pathways

[1]  D. Postma,et al.  Persisting remodeling and less airway wall eosinophil activation in complete remission of asthma. , 2011, American journal of respiratory and critical care medicine.

[2]  J. Rivera,et al.  The tyrosine kinase network regulating mast cell activation , 2009, Immunological reviews.

[3]  W. Henderson,et al.  Mechanisms of disease: Leukotrienes , 2007 .

[4]  J. Kinet,et al.  New developments in FcεRI regulation, function and inhibition , 2007, Nature Reviews Immunology.

[5]  N. Bloksma,et al.  Trimellitic anhydride-conjugated serum albumin activates rat alveolar macrophages in vitro , 2006, Journal of occupational medicine and toxicology.

[6]  Christine Tkaczyk,et al.  Integrated signalling pathways for mast-cell activation , 2006, Nature Reviews Immunology.

[7]  S. Kohno,et al.  Naturally Occurring Parainfluenza Virus 3 Infection in Adults Induces Mild Exacerbation of Asthma Associated with Increased Sputum Concentrations of Cysteinyl Leukotrienes , 2005, International Archives of Allergy and Immunology.

[8]  P. Sterk,et al.  Bronchial CD8 cell infiltrate and lung function decline in asthma. , 2005, American journal of respiratory and critical care medicine.

[9]  F. Graziano,et al.  Peptidoleukotriene (pLT) release from guinea pig lung mast cells , 1994, Inflammation.

[10]  J. Watson,et al.  Multiple antigen challenge produces pulmonary eosinophilia but not pulmonary hyperresponsiveness in actively sensitized guinea pigs , 1992, Agents and Actions.

[11]  J. Lötvall,et al.  Reduced late asthmatic response by repeated low-dose allergen exposure. , 2001, The European respiratory journal.

[12]  C. Janson,et al.  Adult asthmatics sensitized to cats and dogs: symptoms, severity, and bronchial hyperresponsiveness in patients with furred animals at home and patients without these animals , 1999, Allergy.

[13]  É. Vivier,et al.  Biology of immunoreceptor tyrosine-based inhibition motif-bearing molecules. , 1999, Current topics in microbiology and immunology.

[14]  A. H. Koh,et al.  Effects of tyrosine kinase inhibitors on antigen challenge of guinea pig lung in vitro. , 1997, The Journal of pharmacology and experimental therapeutics.

[15]  J. Lötvall,et al.  Bronchial hyperresponsiveness, epithelial damage, and airway eosinophilia after single and repeated allergen exposure in a rat model of anhydride‐induced asthma , 1997, Allergy.

[16]  M. Seeds,et al.  Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. , 1997, American journal of respiratory and critical care medicine.

[17]  M. Turner,et al.  Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. , 1996, Oncogene.

[18]  J. Kinet,et al.  IgE receptor (Fc epsilon RI) and signal transduction. , 1996, The European respiratory journal. Supplement.

[19]  K. Shirato,et al.  Repeated allergen exposure enhances excitatory nonadrenergic noncholinergic nerve-mediated bronchoconstriction in sensitized guinea-pigs. , 1996, The European respiratory journal.

[20]  K. Chung,et al.  Effects of prolonged repeated exposure to ovalbumin in sensitized brown Norway rats. , 1994, American journal of respiratory and critical care medicine.

[21]  O. Zetterstrom,et al.  Increase in non‐specific bronchial responsiveness after repeated inhalation of low doses of allergen , 1993, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[22]  R. Schellenberg,et al.  Role of leukotrienes in airway hyperresponsiveness in guinea‐pigs , 1993, British journal of pharmacology.

[23]  E. Israel,et al.  Recovery of leukotriene E4 from the urine of patients with airway obstruction. , 1992, The American review of respiratory disease.

[24]  J. Lötvall,et al.  A thromboxane mimetic, U-46619, produces plasma exudation in airways of the guinea pig. , 1992, Journal of applied physiology.

[25]  T. Lee,et al.  Urinary leukotriene E4 in bronchial asthma. , 1992, The European respiratory journal.

[26]  K. Chung,et al.  Role of inflammatory mediators in asthma. , 1992, British medical bulletin.

[27]  L. Harrington,et al.  Leukotriene formation by mouse connective tissue mast cells. , 1992, Eicosanoids.

[28]  P. Boschetto,et al.  Plasma exudation. Correlation between Evans blue dye and radiolabeled albumin in guinea pig airways in vivo. , 1989, Journal of pharmacological methods.

[29]  D. V. Van Praag,et al.  Blood leukotriene levels during the acute asthma attack in children. , 1987, Prostaglandins, leukotrienes, and medicine.

[30]  S. Peters,et al.  Central role of cyclooxygenase in the response of canine peripheral airways to antigen. , 1986, Journal of applied physiology.

[31]  R. Naclerio,et al.  Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. , 1984, The New England journal of medicine.

[32]  Robert A. Lewis,et al.  Bronchoconstrictor effects of leukotriene C in humans. , 1982, Science.

[33]  P. Piper,et al.  The mechanism of action of leukotrienes C4 and D4 in guinea-pig isolated perfused lung and parenchymal strips of guinea pig, rabbit and rat. , 1981, Prostaglandins.

[34]  Bengt Samuelsson,et al.  Leukotrienes are potent constrictors of human bronchi , 1980, Nature.